Theradome Review 2026: Is the $995 Laser Helmet Worth It?

Affiliate disclosure: This post contains affiliate links. See our affiliate disclosure for details.

The Theradome PRO LH80 costs $995 and the Theradome EVO LH40 costs $529.99 on Amazon, and Theradome's own comparison page says you will get the same results from either one. That is the review. Everything below is us showing the working.

We run a red light panel at home and have done for over two years, so the dose arithmetic below is familiar ground. We have not worn either helmet. Everything here about the devices comes from Theradome's own spec blocks, both Amazon listings, the FDA's 510(k) database and ClinicalTrials.gov, all fetched on 1 October 2026, plus the published literature on low-level laser therapy. Where a figure comes from the brand rather than an independent measurement, we say so. About BankrollZen sets out exactly where our hands-on experience stops and desk research begins.

Last reviewed: October 2026

If you are still deciding whether a laser cap is worth buying at all, start with our red light therapy for hair loss guide instead. If you have already shortlisted two brands, Theradome vs iRestore goes head to head on the numbers. More red light therapy coverage sits on the category hub.

---

Quick Comparison: Theradome and the caps people cross-shop

Product	Best For	Price	Coverage	Wavelengths	Irradiance (mW/cm²)	Rating
Theradome EVO LH40	Best overall; same weekly dose, far less money	~$529.99 (Amazon)	40 lasers, 587 cm²	680nm ±3nm	Not published	4.0/5
Theradome PRO LH80	Two sessions a week instead of four	~$995	80 lasers, 587 cm²	680nm ±3nm	Not published	3.8/5
iRestore Professional	The one with a published trial behind it	~$899	282 emitters (82 laser / 200 LED)	655nm	Not published (1,410 mW total output)	4.4/5
iRestore Essential	Cheapest way into the category	~$499	120 emitters (51 laser / 69 LED)	655nm	Not published (600 mW total output)	3.9/5
Kiierr 272 Premier	Most lasers for the money	~$1,099.99	272 lasers	Not published on listing	Not published	3.6/5
Hairmax PowerFlex 272	Brand with the deepest trial record	~$1,799	272 lasers	650nm	Not published	3.4/5

Prices and specs checked on 1 October 2026 against theradome.com and each product's Amazon listing, and they move, so confirm before you buy. Four notes. The Theradome PRO is $995 in both places. The EVO is the one worth watching: $529.99 on Amazon from the Theradome Official Store against $695 on theradome.com, so the brand's own shop is the expensive way to buy it. Neither Theradome model publishes an irradiance figure in mW/cm², which is why those cells say "Not published" rather than carrying a number we made up. And the Hairmax row is the PowerFlex 272 cap, not the LaserComb that shows up in the clinical literature. Different products, very different prices.

---

The one calculation Theradome would rather you did not do

Theradome publishes two numbers for each helmet. Nobody in the marketing copy puts them next to each other.

The PRO LH80 spec block states a dosage of 727 Joules delivered per treatment, and the directions say 20 minutes, twice a week. The EVO LH40 spec block states 363 Joules per treatment, and its directions say 20 minutes, four times a week. Both helmets are listed with the same 587 cm² treatment area.

Multiply it out:

• PRO LH80: 727 J × 2 sessions = 1,454 Joules a week
• EVO LH40: 363 J × 4 sessions = 1,452 Joules a week

Two Joules apart, which on a 1,450 Joule base is a rounding error. The EVO is not a weaker helmet. It is the same weekly dose cut into four smaller pieces.

And this is not our inference. Theradome's own PRO vs EVO page says it in plain English: "The PRO LH80 has 80 lasers while the EVO LH40 has 40. This means you will get the same results by using the PRO LH80 2X per week as you will with the EVO LH40 4X per week." The manufacturer is telling you the cheaper helmet gets you to the same place. It just takes two more sittings a week to get there.

Per session, the gap is real: 727 J over 587 cm² is roughly 1.24 J/cm², against roughly 0.62 J/cm² for the EVO. That matters, because per-session fluence is one of the few device variables with a measured association in the literature. A 2020 systematic review of summary-level data across randomised LLLT trials found that each extra 1 J/cm² of per-session fluence was associated with an increase in hair density of 0.23 hairs/cm², with a 95% confidence interval of 0.21 to 0.25 (Gupta and Bamimore, Dermatologic Therapy, PMID 32790116).

Run the Theradome gap through that coefficient and the PRO's extra 0.62 J/cm² a session predicts something in the order of 0.14 hairs/cm². Treat that as a sanity check on the size of the difference rather than a forecast, because applying a cross-study regression to a within-brand comparison is a stretch. But the direction is clear enough: the PRO's per-session advantage is small, and today it costs $465.

There is one finding that genuinely favours the PRO. A 2019 meta-analysis of 11 double-blind RCTs found a larger effect for low-frequency treatment schedules (SMD 1.555, 95% CI 1.132 to 1.978) than for high-frequency ones (SMD 0.949, 95% CI 0.644 to 1.253), and concluded that less frequent treatment appeared to produce better hair growth (Liu et al., Lasers in Medical Science, PMID 30706177). Two sessions a week is the low-frequency arm. Four is not. That is a reason to prefer the PRO, and it is a subgroup analysis in a review the authors themselves describe as limited by heterogeneity, so it is not a reason to pay double.

Where Theradome's own dosage numbers disagree with each other

This took the longest to pin down, and you should know it before you spend $995.

Theradome publishes at least three mutually incompatible dosage figures for the same device. The PRO's product specification block says "Dosage: 727 Joules delivered per treatment". A marketing tile elsewhere on the same site renders it as "727 Joules/cm2 dosage per treatment", which over a 587 cm² scalp would be 426,749 Joules and is not physically plausible. A comparison chart on the same page claims "6 joules/cm² over 20 minute treatment time". The EVO's page carries both "363 Joules delivered per treatment" in the spec block and "6.09 J/cm² Precision Fluence" plus "364 Joules/cm2" in the graphics.

Those cannot all be true. 727 Joules spread over 587 cm² is about 1.24 J/cm², not 6 and not 727. And the EVO cannot deliver the same 6 J/cm² as the PRO from half the Joules over the same area.

We have used the explicit spec-block figures (727 J and 363 J per treatment) throughout, because those are the ones printed in the specification table rather than in a graphic, they are internally consistent with each other, and they are the lower of the available readings. We have not tried to resolve the conflict in Theradome's favour, and we would not build a buying argument on the 6 J/cm² number until somebody measures it.

Theradome's own PRO vs EVO comparison chart adds two more readings to the pile, giving the PRO "727 Joules/cm2" and the EVO "364 Joules/cm2", which is a third unit again and one Joule off the EVO's spec block.

Two more copy-paste errors worth flagging. The EVO's spec block gives its laser lifespan as "If used 2x/week: 18,000 treatments", which is the PRO's schedule; at the EVO's four sessions a week that same 18,000 figure runs out in half the years. And a line on the EVO's own product page reads "Use just twice a week", which is wrong for that helmet. Three other first-party sources settle it at four: the spec block, the how-to-use guide ("use the EVO LH40 4x a week, every other day, for 20 minutes") and the Amazon listing title.

What the clinical record actually says about Theradome

Theradome markets harder on science than almost anyone in this category. The PRO listing says the device is "scientifically proven to stop hair loss in 30 days, visible hair growth in 90 days" and the site states it is effective "for 98% of men and women with androgenetic alopecia". So we went looking for the trial behind that.

Theradome registered one: NCT02528552, a multi-centre, randomised, triple-masked, sham-controlled study of the LH80 PRO in men with androgenetic alopecia, 80 participants planned, with hair growth at 26 weeks as the primary endpoint. Theradome, Inc. is the sponsor. Primary completion is recorded as October 2016, actual. The record was last updated on 1 December 2016, its status on ClinicalTrials.gov is "unknown", and no results have been posted. That is coming up on a decade.

We also checked the 2021 systematic review and meta-analysis of FDA-cleared, home-use LLLT devices in the Journal of Clinical and Aesthetic Dermatology (Lueangarun et al., PMID 34980962), which catalogued all 32 home-use LLLT devices the FDA had cleared as of January 2020 and went through the published RCT evidence device by device. Both Theradome helmets do appear in it, and this is the part worth reading carefully. They appear as two columns in that catalogue of all 32 devices, listing 40 and 80 lasers at 678nm, 20-minute sessions, four times and twice a week. On both columns, the rows for sample size, duration of study and outcome read N/A. That is the only place either helmet is named. HairMax, iRestore, Capillus, iGrow, TOPHAT655 and Revian all turn up elsewhere in the paper, in its device-by-device write-up or its table of trial characteristics; Theradome appears nowhere outside the catalogue. The seven RCTs the meta-analysis actually pools are, by the paper's own tally, one Capillus, two HairMax, two iGrow and two iRestore. We searched the full text.

None of that means the helmets do nothing. The category-level evidence is decent: that same review found a pooled standardised mean difference of 1.27 (95% CI 0.993 to 1.639) for hair density in LLLT versus sham across seven double-blind RCTs. What it means is narrower and more useful. If you want a cap whose exact model has been through a published, peer-reviewed, sham-controlled trial, Theradome is not it, and "clinically proven" on this brand's packaging is doing work that the public record does not support.

The FDA record itself is solid and easy to check. Theradome holds five 510(k) clearances under product code OAP: K113097 (March 2012), K122950 (June 2013), K161046 for the Laser Helmet LH40-EVO (May 2016), K171775 for the Theradome LH80 PRO (January 2018) and K180460 for the Theradome LH40 (May 2018). One discrepancy there. Theradome's own help page says both helmets were cleared for men in January 2018, but the FDA database puts the LH40's clearance in May 2018, four months later. Clearance also means substantially equivalent to an existing device, not proven effective. Our guide to FDA-cleared red light therapy devices explains the difference properly.

Theradome EVO LH40, ~$529.99 on Amazon

The 40-laser helmet, and our pick of the two.

Specs (manufacturer-stated): 40 laser diodes, no LEDs. 680nm ±3nm, VL680 lasers, made in the USA. 363 Joules per treatment. 587 cm² treatment area. 20 minutes, four times a week. 15 ounces. 2,200 mAh lithium-ion battery, micro-USB charging. One-year manufacturer warranty.

Pros

• Same weekly energy as the $995 PRO on Theradome's own figures, for $465 less today
• 100% laser, no LED padding, which is the design choice the research supports
• $529.99 on Amazon against $695 on theradome.com, so the cheap way to buy it is also the one with Amazon's returns behind it
• Cordless and automatic: it shuts itself off at 20 minutes

Cons

• Four sessions a week is 80 minutes of sitting still, and adherence is the thing that kills laser caps
• Half the per-session fluence of the PRO, which is the dose variable the literature can see
• One-year standard warranty
• No published irradiance figure, and no published trial on this model
• Rated 3.6 out of 5 from 174 Amazon ratings, the weakest of the two helmets

Best for: anyone who was about to buy the PRO. Read the arithmetic above first.

Check price →

Theradome PRO LH80, ~$995

The flagship, and the one almost every affiliate review names as the pick.

Specs (manufacturer-stated): 80 laser diodes, no LEDs. 680nm ±3nm, VL680 lasers, made in the USA. 727 Joules per treatment. 587 cm² treatment area. 20 minutes, twice a week. 15 ounces, with foam pads for fit. 2,200 mAh battery. Laser lifespan quoted at 18,000 treatments. One-year manufacturer warranty.

Pros

• Twice the per-session fluence of the EVO, and the low-frequency schedule the 2019 meta-analysis favoured
• 40 minutes a week total, which is the lowest time commitment of any cap here
• Strong satisfaction at the top end: 66% of its 490 Amazon ratings are five stars
• Price is consistent at $995 across Amazon and theradome.com, so you are not being arbitraged

Cons

• $465 more than the EVO for two extra Joules of weekly energy
• The battery is the single biggest owner complaint, and the standard warranty is one year
• 14% of its 490 Amazon ratings are one star, a sharply polarised distribution for a $995 device
• No published trial on this model, and the brand's own registered study has never reported

Best for: people who know from experience that they will not sit under a helmet four times a week. Convenience is a legitimate thing to buy. Just buy it knowing that is what you are buying.

Check price →

What owners actually report

Amazon's own review aggregation on the PRO LH80 is unusually blunt, and it breaks out topic counts, so these are counts rather than impressions. As of 1 October 2026, on 490 global ratings averaging 4.0:

• Reliability: 23 customers mention it, 3 positive, 20 negative.
• Battery life: 20 customers mention it, 6 positive, 14 negative.
• Value for money: 52 customers mention it, 26 positive, 26 negative. A dead-even split.
• Hair shedding: 81 mention it, 67 positive, 14 negative.
• Thickness: 39 mention it, 39 positive, 0 negative.

That is a device people are largely happy with on results and largely unhappy with on hardware. Individual reviews put faces on the battery number: one owner reports the helmet would no longer charge "after only 8 months"; another writes "I'm on my second charger, 3rd battery, it's been 18 months"; a third was quoted $50 for a replacement battery. One 150-session owner reports no results at all. Theradome's customer support gets 10 mentions and 10 of them are positive, which sits oddly beside a one-star review calling support "absolute TRASH", so expect variance there.

That changes what you should actually buy. On a $995 device with a one-year manufacturer warranty, where battery and reliability mentions run 34 negative to 9 positive, the five-year DomeCare extended warranty is not an upsell. It is the thing that makes the purchase defensible. Theradome currently includes it in its bundle, which brings us to the pricing.

About that struck-through price

Both Theradome product pages show a crossed-out higher number: $1,428.99 on the PRO and $1,028.99 on the EVO, with "$430+ savings" and "$330+ value" alongside.

That is not a device discount. The PRO's bundle is $995 for the helmet plus a five-year DomeCare warranty listed at $295, a Hair Growth Bundle at $129 and an eBook at $9.99, which sums to exactly $1,428.99. The EVO's works the same way at a smaller scale. So $995 and $695 are the standing prices of the helmets, and the "saving" is the retail value of the extras bundled with them.

Which does not make the extras worthless. Given the battery complaint pattern above, a five-year replacement warranty normally priced at $295 is the most valuable thing in that bundle by a wide margin. Just do not read the strike-through as a sale you need to rush.

The other price worth repeating: the EVO is $529.99 on Amazon from the Theradome Official Store and $695 on theradome.com. Buying from the brand costs $165 more.

Buyer's guide: how to choose, in order

Work out how many sessions a week you will genuinely do

This is the only question that matters, and it is about you rather than the hardware. Four 20-minute sessions is a real commitment. If you know yourself to be the sort of person who abandons a routine by week three, the PRO's twice-weekly schedule is worth money. If four sessions is fine, the EVO is the same weekly dose for $465 less.

Do not pay for diode count

Theradome's central marketing claim is that its 80 lasers beat rivals' hundreds of diodes, phrased as 80 car batteries against 500 watch batteries. iRestore sells the mirror image, with 282 or 500 emitters as the headline. Both are selling you a number the research cannot see. The 2020 review found that the number of lasers or LEDs "is not significantly associated with change in hair density" (PMID 32790116). Dose, session duration and pulsing showed significant effects. Emitter count did not.

Do pay for laser rather than LED, because that one holds up

Here Theradome is right, and it deserves saying plainly. Two independent analyses found laser-only devices outperformed laser/LED mixtures: a meta-analysis of photobiomodulation for androgenetic alopecia found laser treatment significantly more effective than a laser/LED combination across 15 studies and 795 pooled participants (p = .009, Gupta and Carviel, PMID 31746251), and the 2021 FDA-device review found a pooled SMD of 1.52 (95% CI 1.16 to 1.88) for laser-diode-only devices against 0.85 (95% CI 0.55 to 1.16) for combinations (p = 0.043, PMID 34980962). Both Theradome helmets are 100% laser. The iRestore models that cross-shop against them are not.

Budget for the warranty, not the helmet

Add the five-year DomeCare cover to your mental price if it is ever not bundled. On the owner-report pattern above, a laser helmet is a device where the battery, not the lasers, is likely to end your ownership.

Expect six months before you judge it

The registered endpoints in this field are at 16 and 26 weeks for a reason. Theradome's own marketing promises visible growth at 90 days. The published trials that found an effect ran longer than that.

FAQ

Does the Theradome actually work?

The category-level evidence is reasonably good and the device-level evidence is missing. A 2021 meta-analysis of seven double-blind RCTs of FDA-cleared home-use laser devices found a pooled standardised mean difference of 1.27 (95% CI 0.993 to 1.639) for hair density against sham. None of those trials used a Theradome. Theradome's own registered study, NCT02528552, completed its primary endpoint in October 2016 and has never posted results. So the honest answer is that low-level laser therapy for androgenetic alopecia has decent published support, and Theradome specifically does not have its own published trial.

Is Theradome FDA approved?

No device in this category is FDA approved. Theradome is FDA cleared, which is different. It holds five 510(k) clearances under product code OAP, including K171775 for the LH80 PRO in January 2018 and K180460 for the LH40 in May 2018. Clearance means the FDA accepted the device as substantially equivalent to one already on the market. It is not a finding that the device works.

How much does a Theradome cost?

As of 1 October 2026, the PRO LH80 is $995 on both Amazon and theradome.com. The EVO LH40 is $529.99 on Amazon from the Theradome Official Store and $695 on theradome.com. The higher struck-through figures on the brand's site ($1,428.99 and $1,028.99) are bundle totals that include a five-year warranty and accessories, not former prices for the helmet on its own.

What is the difference between the Theradome PRO LH80 and the EVO LH40?

The PRO has 80 lasers and the EVO has 40, and both cover the same stated 587 cm². The real difference is the schedule. The PRO delivers 727 Joules twice a week and the EVO delivers 363 Joules four times a week, which comes to 1,454 and 1,452 Joules a week respectively. Theradome's own PRO vs EVO page puts it bluntly: "you will get the same results by using the PRO LH80 2X per week as you will with the EVO LH40 4X per week." You are buying two fewer sessions a week, not more light.

How long does it take to see results from Theradome?

Theradome's marketing says hair loss stops in 30 days and growth is visible in 90. The published trials in this field measure their primary endpoints at 16 to 26 weeks, so four to six months is a more realistic window before you decide whether it is working. Several owner reports describe an initial shedding phase before any improvement.

Is Theradome better than iRestore?

They are built on opposite bets. Theradome is 100% laser at 680nm with a low session count, and the laser-only design is supported by two separate meta-analyses. iRestore mixes laser diodes with LEDs at 655nm but publishes a total power output and has a model that appears in the published literature. Our Theradome vs iRestore comparison works through both brands' own spec sheets in full.

How long does the Theradome battery last?

Theradome quotes a 2,200 mAh battery and a laser lifespan of 18,000 treatments at twice-weekly use. Owner reports tell a different story about the battery specifically: of 20 Amazon reviewers who mention battery life on the PRO LH80, 14 are negative, with failures described at 8 and 18 months, and one owner quoted $50 for a replacement. The standard manufacturer warranty is one year, which is why the five-year DomeCare cover matters.

Our Verdict

If we were buying a Theradome today we would buy the EVO LH40 on Amazon at $529.99 and keep the $465. Theradome's own comparison page says you get the same results either way, and its spec sheets back that up at 1,452 Joules a week against 1,454. The premium buys a schedule, not a dose. The brand's strongest claim is also its most defensible one: these are 100% laser helmets with no LED padding, and that is the one design variable in this category that two independent meta-analyses have actually found to matter.

What stops us rating either helmet higher is the gap between the marketing and the record. A device sold on "scientifically proven" ought to have a published trial, and the one Theradome registered in 2015 has been sitting at unknown status with no posted results since December 2016. Add a one-year warranty on hardware whose battery draws 14 of 20 owner mentions negatively, and the five-year cover stops being optional. If published device-specific evidence is what you want for your money, the iRestore Professional at $899 is the cap that appears in the literature.